Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management

Key Findings

• ●ISM median survival 198 months (near-normal)
• ●ASM median survival 41 months
• ●SM-AHN median survival 24 months
• ●MCL median survival 2 months

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.